Suppr超能文献

钴胺素缺乏的临床谱与诊断

Clinical spectrum and diagnosis of cobalamin deficiency.

作者信息

Stabler S P, Allen R H, Savage D G, Lindenbaum J

机构信息

Department of Medicine, University of Colorado Health Sciences Center, Denver 80262.

出版信息

Blood. 1990 Sep 1;76(5):871-81.

PMID:2393714
Abstract

To better estimate how frequently patients with low serum cobalamin (Cbl) levels in current clinical practice are truly deficient in Cbl and to determine the incidence of atypical or nonclassic presentations of Cbl deficiency, we prospectively studied 300 unselected consecutive patients with serum Cbl concentrations less than 200 pg/mL seen at two medical centers over a 2-year period. Baseline hematologic, neuropsychiatric, and biochemical measurements were obtained, followed by a course of parenteral Cbl therapy and reassessment. A response to Cbl therapy was defined as one or more of the following: (1) an increase in hematocrit of 0.05 or more; (2) a decrease in mean cell volume of 5 fL or more; (3) a clearing of hypersegmented neutrophilis and macroovalocytes from the peripheral blood smear; and (4) an unequivocal and prompt improvement of neuropsychiatric abnormalities. Of the 300 patients with serum Cbl levels less than 200 pg/mL, 86 had one or more responses to Cbl therapy and 59 had no response. In 155, insufficient data was available. In the Cbl-responsive patients, normal values were found for the following tests: hematocrit, 44%; mean cell volume less than or equal to 100 fL, 36%; white blood cell count, 84%; platelet count, 79%; serum lactic dehydrogenase, 43%; and serum bilirubin, 83%. Peripheral blood smears were nondiagnostic in 6% when reviewed by the investigators, but 33% as reported by routine laboratories. Serum Cbl levels in the 100 to 199 pg/mL range were present in 38%. Neuropsychiatric abnormalities were noted in 28%, often in the absence of anemia, macrocytosis, or both. Serum levels of methylmalonic acid and/or total homocysteine were elevated greater than 3 SDs above the mean for normal subjects in 94% of the Cbl-responsive patients. We conclude that Cbl deficiency should be considered and investigated in patients with unexplained hematologic or neuropsychiatric abnormalities of the kind seen in Cbl deficiency, even if anemia, an elevated mean cell volume, a marked depression of the serum Cbl, or other classic hematologic or biochemical abnormalities are lacking. Levels of serum methylmalonic acid and total homocysteine are useful as ancillary diagnostic tests in the diagnostis of Cbl deficiency.

摘要

为了更好地估计在当前临床实践中血清钴胺素(Cbl)水平低的患者真正缺乏Cbl的频率,并确定Cbl缺乏的非典型或非经典表现的发生率,我们对两家医疗中心在两年期间连续接诊的300例未经过挑选的血清Cbl浓度低于200 pg/mL的患者进行了前瞻性研究。获取了基线血液学、神经精神学和生化指标,随后进行了一个疗程的肠外Cbl治疗并重新评估。对Cbl治疗的反应定义为以下一项或多项:(1)血细胞比容增加0.05或更多;(2)平均细胞体积减少5 fL或更多;(3)外周血涂片上的多分叶中性粒细胞和大卵圆形红细胞消失;(4)神经精神异常明确且迅速改善。在300例血清Cbl水平低于200 pg/mL的患者中,86例对Cbl治疗有一项或多项反应,59例无反应。155例患者数据不足。在对Cbl有反应的患者中,以下检查结果正常:血细胞比容,44%;平均细胞体积小于或等于100 fL,36%;白细胞计数,84%;血小板计数,79%;血清乳酸脱氢酶,43%;血清胆红素,83%。研究者复查时外周血涂片无诊断意义的占6%,但常规实验室报告为33%。血清Cbl水平在100至199 pg/mL范围的患者占38%。28%的患者有神经精神异常,且常无贫血、大细胞性贫血或两者皆无。94%对Cbl有反应的患者血清甲基丙二酸和/或总同型半胱氨酸水平高于正常受试者平均值3个标准差以上。我们得出结论,对于出现Cbl缺乏时所见的无法解释的血液学或神经精神异常的患者,即使缺乏贫血、平均细胞体积升高、血清Cbl显著降低或其他经典血液学或生化异常,也应考虑并调查Cbl缺乏。血清甲基丙二酸和总同型半胱氨酸水平在Cbl缺乏的诊断中作为辅助诊断试验很有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验